The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)
Official Title: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)
Study ID: NCT03022448
Brief Summary: The aim of the non-interventional study is to prospectively collect and analyze data on the geriatric assessment of patients undergoing systemic 1st line therapy with trabectedin with focus on patients who have been assessed by the treating physician as being unsuited to receive standard chemotherapy with anthracyclines and / or ifosfamide. Trabectedin will be used according to the local SmPC. Modification of the treatment schedule should follow the standard medical practice at the discretion of the treating physician and is not part of this Observational Plan.
Detailed Description:
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Klinikum Klagenfurt am Wörthersee, Klagenfurt, , Austria
Medizinische Universität Wien, Wien, , Austria
HELIOS Klinikum Bad Saarow, Bad Saarow, , Germany
HELIOS Klinikum Berlin Buch, Berlin, , Germany
Klinikum Spandau, Berlin, , Germany
Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, , Germany
Universitätsklinikum Heidelberg, Heidelberg, , Germany
University of Heidelberg Mannheim University Medical Center Interdisciplinary Tumor Center, Sarcoma Unit, Mannheim, , Germany
Klinikum Nürnberg Nord, Nürnberg, , Germany
Universitätsklinikum Ulm, Ulm, , Germany
Universitätsspital Bern, Bern, , Switzerland
Kantonsspital St. Gallen, Saint Gallen, , Switzerland
Name: Bernd Kasper, Prof.
Affiliation: University of Heidelberg Mannheim University Medical Center Interdisciplinary Tumor Center, Sarcoma Unit
Role: PRINCIPAL_INVESTIGATOR